Where are we going? I think we have already gone,
Post# of 148187
On not releasing the NASH data, SK already said he thought we have a NASH drug. If Recknor found a new MOA, why release this info in January and give other companies a 6 month headstart aiming their drugs in this direction? The info will be released when we are ready to proceed.
Amarex is in process, but I think the FDA said you need to do XYZ to move forward which is what is happening.
I think everything got pretty much agreed upon at CYDY when the CC was cancelled in December leading to Nader leaving voluntarily in January and SK stepping down as COB.
My guess is the great reveal comes in late June with a new CEO and two new Board members coming in. Did you catch Tanya’s comment about looking for board members with two different skill sets yet we only have one open seat? think another CYDY board member will also voluntarily step down.